FIELD: medicine.
SUBSTANCE: invention refers to medicine, particularly to endocrinology and ophthalmology. Method comprises administering a medicinal mixture into a lymphatic region of an orbit on the side of the involved eye by performing pterygo-palatine blockades, wherein the medicinal mixture contains: lidocaine 20–40 mg, gemase 3000–5000 units, dexazone 4–8 mg, xefocam – 4.0–8.0 mg, dalargin 1–2 mg. That is followed by 6–8 blockades alternating the right and left eye orbits every second day.
EFFECT: method provides higher clinical effectiveness, reduces labor intensity and reduces the risk of collateral complications.
1 cl, 2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR THE TREATMENT OF OPTIC NEUROPATHY IN PATIENTS WITH EDEMATOUS EXOPHTHALMOS | 2020 |
|
RU2742188C1 |
| METHOD OF TREATING ENDOCRINE AUTOIMMUNE OPHTHALMOPATHY | 2024 |
|
RU2819981C1 |
| METHOD OF COMBINED CONSERVATIVE TREATMENT OF ACTIVE ENDOCRINE OPHTHALMOPATHY | 2022 |
|
RU2806503C1 |
| METHOD FOR TREATING PATIENTS FOR RECURRENT UVEITIS | 2005 |
|
RU2299065C1 |
| METHOD OF TREATING ENDOCRINE OPHTHALMOPATHY | 2012 |
|
RU2483723C1 |
| METHOD FOR TREATING THE CASES OF POSTOPERATIVE INFLAMMATORY COMPLICATIONS AFTER CATARACT EXTRACTION AND ARTIFICIAL EYE LENS IMPLANTATION | 2005 |
|
RU2290203C1 |
| METHOD OF POST COSMETIC SURGERY REHABILITATION | 2008 |
|
RU2366413C1 |
| METHOD FOR TREATING THE CASES OF POST-INFLAMMATION BULLOUS KERATOPATHY | 2002 |
|
RU2218896C1 |
| METHOD OF TREATING INFLAMMATORY OR DYSTROPHIC EYE DISEASES | 2019 |
|
RU2714193C1 |
| METHOD FOR TREATING OEDEMATOUS FORM OF DIABETIC MACULORETINOPAHTY | 2008 |
|
RU2367386C1 |
